Oncolytics Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.66

-0.02 (-2.97%)

As of Sep 28, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +2,945.2% upside

Low Target $14.44

Average Target $20.19

High Target $28.89

Current Price $0.66

Current
$0.66

Target
$20.19

$14.44 $20.19 avg $28.89

Scenario Analysis

Bear Case

$14.44

2,078.0%

Low target

Base Case

$20.19

+2,945.2%

Avg target

Bull Case

$28.89

+4,257.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$4.49

-85.2% from high

52-Week Low

$1.48

+-55.2% from low

Target vs 52W High

$20.19

+349.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%